CD4 and neoplasm: In the TME, CAFs-secreted CCL2, CCL5, CCL17, IL-1, IL-6, IL-13, and IL-26 can also promote a Th2 and Th17 CD4+ polarization, at the expense of anti-tumor Th1 response [33, 159–161].